Insider Trading & Ownership of William F. Doyle

Location
Portsmouth, NH
Summary
The estimated net worth of William F. Doyle is at least $5,813,268 dollars as of 05 Mar 2026. William F. Doyle is the Executive Chairman, Director of NovoCure Ltd and owns shares of NovoCure Ltd (NVCR) stock worth about $4.41M. William F. Doyle is the Director of Elanco Animal Health Inc and owns shares of Elanco Animal Health Inc (ELAN) stock worth about $1.4M.
Signature
Steven Robbins, as attorney in fact for Doyle, William F
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow William F. Doyle and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • William F. Doyle has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,813,268.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: NovoCure Ltd ($4,409,977).
  • Past-year value change for that position: -$932,883.

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of William F. Doyle

PROK Forms 3/4/5

PROKIDNEY CORP.

Relationship
Director
Holdings value
Past year net change
Change %
Report period
29 May 2025

Insider Transactions Reported by William F. Doyle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .